Hidemitsu Kitamura

7PUBLICATIONS
21CO-AUTHORS
Innate immunityMolecular targetsHaematological tumoursAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 01, 2024
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I.

Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda

|Jan 30, 2023
IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8+ T cells in vivo.

Weidong Shen, Xiangdong Wang, Huihui Xiang

|Aug 01, 2022
STAT1-mediated induction of Ly6c-expressing macrophages are involved in the pathogenesis of an acute colitis model.

Shuhei Kii, Hidemitsu Kitamura, Shinichi Hashimoto

|May 13, 2022
IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.

Huihui Xiang, Yujiro Toyoshima, Weidong Shen

|Sep 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes.

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato

|Jul 28, 2017
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.

Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima

Pageof 2

Frequent Collaborators

1 joint publications

Akemi Kosaka

1 joint publications

Kei Ishibashi

1 joint publications

Toshihiro Nagato

1 joint publications

Yukio Fujiwara